Dave Stancliff U.S. doctors concerned over generic drug quality from India blogarama.com

Wednesday, March 19, 2014

U.S. doctors concerned over generic drug quality from India

Good Day World!

I’m wondering how many generic drugs I take (or have taken) that came from Indian manufacturers.

The reason I bring this up is some U.S. doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.

India supplies about 40 percent of generic and over-the-counter drugs used in the United States, making it the second-biggest supplier after Canada.

In recent months, the FDA, citing quality control problems ranging from data manipulation to sanitation, has banned the importation of products from Ranbaxy Laboratories Ltd, Wockhardt Ltd and, most recently, Sun Pharmaceutical Industries Ltd.

FDA Commissioner Margaret Hamburg, who recently returned from her first official visit to India, is urging greater collaboration between the two countries. During her visit, the FDA and India's Ministry of Health and Family Welfare signed a statement of intent to cooperate to prevent the distribution of unsafe drugs.

Shortly afterwards, India's drug controller general, G.N. Singh, said in an interview that the country will follow its own quality standards. "The FDA may regulate its country, but it can't regulate India on how India has to behave or how to deliver."

I don’t know about you, but it doesn’t sound like things are really going to be changing soon to me. India flipped us the bird and basically said, “Take it or leave it buddy!”

Excuse me…I’ve got to find my meds and see if I can’t start getting the “real” thing from here on out.

Time for me to walk on down the road…

 

No comments: